Trials / Completed
CompletedNCT04801745
Vegan Diet, Amla Fruits and Uric Acid
Effects of a Healthy Vegan Diet Vs. Low Purine Diet, with or Without Amla Fruits (Emblica Officinalis) on Hyperuricemia and Other Cardiometabolic Risk Factors: a Randomized Two-by-two Factorial Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- Fu Jen Catholic University · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This is an intervention study aiming to test the effectiveness of a vegan diet, My Plate with low purine choices, and amla fruits on uric acid and other cardiometabolic risk factors in individuals with high serum uric acid levels.
Detailed description
Ninety-two participants with hyperuricemia will be randomly assigned to one of these 4 diet interventions: (1) vegan, (2) vegan with amla fruits, (3) my plate-low purine, (4) my plate-low purine with amla fruits. During the 3 months intervention phase, participants will attend group lessons and individual nutrition counseling sessions to assist adherence to the diet. At baseline, end of 3 months, and 1 year, participants will be measured on uric acid and other cardiometabolic risk factors, and some nutritional markers. Amla fruits powder, and some foods encouraged in each dietary arm will be provided to enhance adherence during the 3 months intervention phase.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Healthy vegan diet | Participants will attend group lessons and individual nutrition counseling to help them adopt a healthy vegan diet. |
| OTHER | My Plate - Low Purine | Participants will attend group lessons and individual nutrition counseling to help them adopt a balanced diet in accordance with my plate, and emphasis on choosing low purine options from the protein food groups. |
| OTHER | Amla fruits | Participants will be provided with powdered amla fruits, and will be instructed to take 3g per day. |
Timeline
- Start date
- 2021-03-20
- Primary completion
- 2024-01-30
- Completion
- 2024-01-30
- First posted
- 2021-03-17
- Last updated
- 2024-10-03
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04801745. Inclusion in this directory is not an endorsement.